Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6G9N

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU FR-X
Temperature [K]100
Detector technologyPIXEL
Collection date2016-01-28
DetectorDECTRIS PILATUS 300K
Wavelength(s)1.54178
Spacegroup nameP 1 21 1
Unit cell lengths48.904, 70.324, 60.747
Unit cell angles90.00, 110.38, 90.00
Refinement procedure
Resolution28.250 - 1.760
R-factor0.168
Rwork0.165
R-free0.21800
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.013
RMSD bond angle1.080
Data reduction softwareXDS
Data scaling softwareAimless
Phasing softwareBUSTER
Refinement softwareBUSTER (2.11.7)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]28.2501.810
High resolution limit [Å]1.7601.760
Rmeas0.0310.528
Number of reflections375332716
<I/σ(I)>22.5
Completeness [%]98.290.4
Redundancy2.7
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7.22932M (NH4)2SO4 34% MPEG 2000 .02M Mercaptoethanol .1M pH=7.2 HEPES/NaOH

246031

PDB entries from 2025-12-10

PDB statisticsPDBj update infoContact PDBjnumon